• REZYFi is a specialized financing company in the U.S., originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties
• Target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing
• Currently licensed in 36 states, with plans for expansion into all states, REZYFi is leveraging its experience, a network of independent brokers, and proprietary technology, to enhance its offering within target markets
• REZYFi operates through two wholly-owned subsidiaries – REZYFi Lending and ResMac, Inc. – offering financial services and direct lender/originator options across a large network of correspondents

The cannabis industry overall has been experiencing significant growth, with double-digit rates, and companies are competing to gain a significant market share. Leading players in the cannabis market are undertaking inorganic growth strategies, including expansions, investments, and acquisitions, to increase their profits and share of the market. The worldwide market is expected to be valued at $27.7 billion in 2022 and projected to reach $82.3 billion by 2027, recording a CAGR of 24.3%, driven by the increased legalization of cannabis for recreational and medical purposes use in countries (https://ibn.fm/8xmWf). Mortgage lender company REZYFi, servicing the needs of both traditional and non-traditional consumers and businesses, is positioned to be one of the first cannabis mortgage bankers in the United States – an industry where many traditional lenders are reticent to serve the state-licensed cannabis industry. REZYFi operates through two wholly-owned subsidiaries: REZYFi Lending – leveraging a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA loans, VA loans, reverse mortgages, jumbo loans, and adjustable-rate mortgages, REZYFi Lending expects increased funding in marketing and loan agents to drive origination growth over the next two years, which is supported by its planned launch of a high-margin cannabis division later this year. ResMac, Inc. – in operation for 13 years, ResMac, Inc. allows REZYFi to operate as a direct lender and originator of residential mortgages, with active mortgage correspondent and mortgage servicing operations. ResMac primarily purchases and aggregates residential mortgages through its correspondent segment from trusted third-party originators. The subsidiary has closed more than 20,000 loans for more than 15,000 clients and expects to accumulate $285 million in retail origination in 2023. With its corporate strengths, REZYFi’s diversified approach to the real estate lending sector positions it to capitalize on growth in multiple verticals due to its experience, a network of independent brokers, and proprietary technology. Led by a seasoned management team, REZYFi has been built from the extensive experience of its leaders in real estate, financing subsectors, and the cannabis and hemp marketplace. Over the last five years, management has developed an extensive network of independent mortgage-related brokers and is currently training the network members on the company’s new service offerings, with many already launching new sales efforts. Currently licensed in 36 states, with plans to operate nationwide, REZYFi has invested heavily in designing, building, and implementing proprietary automated/machine learning technology to shorten loan processing timeframes and increase efficiencies. This allows the company to operate its legacy business at staffing levels meaningfully below its competitors. This unique advantage allows REZYFi to leverage its target markets and excel in areas where traditional banking institutions are still hesitant. For more information, visit the company’s website at www.REZYFi.com. NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://ibn.fm/REZY

• Cannabis grower and product maker Flora Growth is developing its own approach to riding troubling economic forces, boasting a 604 percent YOY increase in the H1 reporting period this year
• Market analysts predict the global cannabis market’s value will rise during the next five years at a CAGR of 24.3 percent to arrive at annual valuation of $82.3 billion
• Flora Growth is levying the potential of recent cooperative agreements to increase the reach of its product distribution pipeline, including new exports to Switzerland, the Czech Republic and the United States
• Europe is predicted to be the fastest-growing region for cannabis sales during the next few years as a result of Europeans’ recognition of cannabis’ medical benefits and the ongoing advance of legalization

Cannabis cultivator, brand manufacturer and global distributor Flora Growth (NASDAQ: FLGC) is offering a bit of pain relief to economies battered by recent uncertainty over a costly worldwide pandemic, a war in Europe’s breadbasket and the retail supply chain disruptions that have resulted from them. The Canadian company with a productive base of operations in Colombia’s fertile greenbelt is licensed to cultivate cannabis on a 100-hectare (about 247-acre) farming facility and then deliver its product to its GMP-certified processing facility in the nation’s capital, where beauty, phytotherapeutic and nutraceutical products are prepared for market. And analysts foresee that market continuing to burst with opportunities. Reportlinker.com stated last month that it expects the global cannabis market to end the year with a valuation of $27.7 billion and to grow at a CAGR of 24.3 percent through 2027 to achieve $82.3 billion in sales at the conclusion of the next five years. Europe is expected to be the fastest-growing region. “The market in Europe is majorly driven by the awareness of medical benefits of cannabis in the region coupled with the healthcare system present in several European countries that covers the health expenditure of most patients in these regions. As the legalization of cannabis in European countries is at a nascent stage, this creates a considerable opportunity for companies to establish themselves in the region,” the report states (https://ibn.fm/EsfMY). Flora’s brand division is focused on developing plant-based consumer products, such as cannabinoid-infused juices, gummies, topicals, inhalables, and skin care. But the company also prioritizes the manufacture of “cannabinoid-derived medical formulations that can be sold domestically and internationally” (https://ibn.fm/iLRtv). In September, the company announced that it had completed its first exports of high-CBD dried cannabis flower to Switzerland and the Czech Republic and of CBD isolate to the United States. “We are proud to help increase access to safe, legal CBD and THC to consumers all over the globe,” Flora Growth Chairman and CEO Luis Merchan stated at the time (https://ibn.fm/BGNc5). “We look forward to working closely with our partners in Europe and North America to bring high-quality Colombian cannabis products and raw materials to market.” Flora has pursued acquisitions and partnerships that will help its distribution supply chain grow. Two recent examples include the receipt of about 75 SKUs from the No Cap Hemp Co. brand and a collaboration with Colombia’s Misak indigenous tribe’s pharmaceutical arm to speed up the fulfillment of company cannabis exports by taking advantage of the tribe’s approved license for medicinal and scientific use cannabis. The agreements are helping Flora to effectively improve its profitability through overhead management and vigilance in regard to working capital. “With all three of our core pillars generating revenue in the second half of 2022 … we believe we have a path to profitability that few global cannabis companies can achieve in this difficult environment,” Merchan stated in August (https://ibn.fm/kAshT). For more information, visit the company’s website at www.FloraGrowth.com. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• Reklaim appears poised to capitalize on new market opportunities for companies with a competitive edge in compliant data; it seeks to position itself as the go-to privacy-compliant data partner
• Shifting data-protection regulations and stricter privacy policies of Big Tech companies like Apple and Google require brands to replace their existing data suppliers with those compliant with new privacy standards
• Reklaim’s platform allows consumers to claim control of their personal data while brands can buy and sell consumer-consented privacy-compliant data

As the era of online tracking and monetizing consumer data without explicit consent is coming to an end, companies like Reklaim (TSX.V: MYID) (OTCQB: MYIDF) that provide consumer data compliant with government regulations are set to benefit in this rapidly evolving environment. Driven by the transformation of consumer privacy regulations and how Big Tech has adapted to this changing consumer sentiment and legislation, Reklaim appears poised to position itself as the go-to solution for businesses under swelling pressure to find a partner to solve this compliance gap. In an increasingly noisy digital environment, brands rely on consumer data for targeted marketing to better personalize their online presence to match their intended audience’s preferences. Until recently, so-called Big Tech companies – such as Facebook, Google, Amazon, and the like – were collecting immense amounts of personal information about consumers and selling it to the highest bidder without consumers’ knowledge or explicit consent. But under the pressure of changing regulations, the $400-billion data market is about to transform (https://ibn.fm/VLsQZ). As companies like Apple and Google align their products with the shifting regulation, making tracking consumers’ online behavior more challenging, digital data monetization becomes much more complicated. As a result, a drastic reduction in reliable data supply is expected. “The global data market has historically been built on collecting data unbeknownst to consumers and arbitraging it to as many different firms as possible for as much money as possible,” said Neil Sweeney, founder and CEO of Reklaim (https://ibn.fm/V1KgW). “This is quickly coming to an end, not only with accelerating changes in privacy legislation but also in how companies such as Google and Apple are quickly reducing the amount of data leaking from their products.” With the days of cookies and retargeting ads gone, brands are forced to rethink their marketing strategy – and access to consumer-consented data purchased from a compliant supplier with scale is deemed the critical step towards advertising in the modern, privacy-first world. With access to over 320 million profiles in the US alone, Reklaim emerges as a partner that can respond to these privacy challenges (https://ibn.fm/dBvk9). Its unique data platform serves consumers and brands alike. The company prides itself on being the world’s only company providing consumers with access to the digital information companies collected about them and guaranteed weekly monetization. They can view, edit, opt out, or be compensated when businesses use their data. At the same time, the platform allows brands and companies to buy and sell consumer-consented, privacy-compliant data. Considered an industry leader amid a growing broader trend that still goes largely unnoticed as the US is slowly but surely shifting toward a federally driven privacy policy, the company’s vision seems to be coming to fruition. After decades-long efforts to pass a law to protect Americans’ data privacy, a bipartisan draft bill recently released by key Congressional leaders indicates that a patchwork of state and sector-specific data privacy laws is about to be replaced by a comprehensive federal consumer privacy framework (https://ibn.fm/rhTbS). This modern world of privacy-protected data opens new opportunities for companies with a competitive edge in privacy-compliant data. As businesses re-evaluate their data suppliers over the next 12 months, Reklaim reveals plans to explore strategic M&A opportunities involving data partners that struggle with compliance issues amid the rapidly changing privacy market. As times are changing and consumers demand better protection of their online privacy, Reklaim appears well positioned to benefit from the emerging privacy landscape in which brands must have a reliable partner to ensure privacy-compliant data authorized by consumers. For more information, visit the company’s website at www.ReklaimYours.com. NOTE TO INVESTORS: The latest news and updates relating to MYIDF are available in the company’s newsroom at https://ibn.fm/MYIDF

• CO2 concentrations in the atmosphere are at the highest of the modern record era
• EverGen develops and operates renewable natural gas projects that significantly reduce pollutants like CO2 and methane
• With major customers and partners, EverGen has expanded from a single facility in British Columbia to a series of projects across Canada

Natural gas prices are soaring around the world, partly contributing to the inflation in Europe that has risen to a record 10% in September. At the same time, citizens in New Jersey gripe over state regulators approving natural gas rate hikes that went into effect Saturday ahead of the cold weather season. While prices rise and all eyes are on natural gas, the climate change debate rages on. Throwing fuel into the fire, a special supplement to the bulletin of the American Meteorological Society that was released in August, paints an eye-popping picture of the level of carbon dioxide (“CO2”) in the atmosphere. Decarbonization isn’t easy, but thankfully, there are companies like EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF) that are rising to the challenge to provide RNG solutions for utilities who are increasingly looking to reduce the world’s dependence on fossil fuels and slash pollution. According to the report, CO2 concentrations increased 2.6 parts per million in 2021 from 2020, the fifth-higher growth rate since the start of the instrumental record in 1958. The increase pushed CO2 concentration in the atmosphere to the highest of the modern record era and ice core records dating back 800,000 years. Not to be left out, methane (“CH4”) concentrations in 2021 were also at a record high. Methane comes from a variety of anthropogenic and natural sources, such as landfills, oil and natural gas systems, and agricultural activities, amongst other things. There are emerging technologies (i.e., low-carbon hydrogen, carbon capture, utilization, and storage) to neutralize the environmental effect of natural gas that will be available in the future. In the meantime, companies and utilities are increasingly turning to RNG, also called biogas, as an option to natural gas extracted from the Earth. RNG is produced from decomposing organic waste from landfills, agricultural waste, and wastewater from treatment facilities. The process includes using anaerobic (devoid of oxygen) digestors to break down waste to produce biogas and digestate. The biogas is purified and used for heat and electricity or as biomethane for the natural gas grid or for powering vehicles. Digestate puts to use captured nutrients like nitrogen and phosphorus, using it for products such as fertilizer and livestock bedding. Not only is the waste used productively for sustainable products, but usage as feedstock also prevents natural decomposition in landfills or storage ponds, meaning significant levels of methane are kept from being released into the atmosphere. Climate change awareness has consumers, regulators and companies alike clamoring about implementing sustainable alternatives to natural gas, driving demand for RNG. This benefits EverGen, which has contracts with utilities and municipalities to produce and sell its RNG. EverGen was initially focused within its home province of British Columbia, where it owns three projects – Fraser Valley Biogas, Net Zero Waste Abbottsford, and Sea to Sky Soils – before it began expanding eastward across the country. The company is amid an expansion at Fraser Valley Biogas that will double RNG production to ~160,000 gigajoules (“GJ”) per year as part of a longer-term strategy to reach 1,000,000 GJ. EverGen’s projects are all structured via long term offtake agreements, and they already have a buyer who has been eagerly looking for new RNG supply. As testament to this, last week, EverGen signed a term sheet for a long-term offtake agreement that would replace and expiring agreement for RNG production at Fraser Valley. Pursuant to the new terms, the buyer commits to purchasing up to 190,000 GJ annually from the facility. To the east, EverGen has a 67% stake in GrowTEC, a multi-faceted bioenergy venture located on the Perry Family farm outside Lethbridge, Alberta that includes and operating biogas facility. The facility is slated to be modified to produce RNG that will be sold to FortisBC and tied into the local pipeline network. FortisBC is bullish on RNG, using it as part of its initiative to make a minimum of 15% of its gas supply carbon neutral by 2030. Most recently, EverGen acquired a 50% interest in Project Radius, a late-development stage portfolio of three high-quality RNG projects that will serve as the foundation of EverGen’s portfolio in Ontario. This project will cement EverGen’s position in the populous province that has copious amounts of organic feedstock. Collectively, the RNG output at the projects is estimate at 1,700,000 GJ annually. For more information, visit the company’s website at www.EvergenInfra.com. NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

• The concussion controversy surrounding Tua Tagovailoa has prompted both the NFL and the NFLPA to revisit the league’s concussion protocol in a move designed to enhance player safety
• In the wake of this controversy, Odyssey is emphasizing the potential value of its PRV-002 novel compound for the treatment of concussions and the benefit of the players
• According to a report published by Vox, there are approximately 0.41 concussions per NFL game in American football, with 9.3% of concussions involving the loss of consciousness and 2.4% resulting in hospitalizations
• With such cases, there is a need to revise the NFL’s concussion protocol and push for a treatment option that is effective in the treatment of this condition
• Odyssey is at the forefront of a possible pharmaceutical treatment option, as it advances its clinical trials, to potentially receive FDA approval

Odyssey Health (OTC: ODYY) is looking to push its PRV-002 novel compound for the treatment of concussions given the National Football League (“NFL”) and National Football League Players Association’s (“NFLPA”) joint announcement on changes to the league’s concussion protocol (https://ibn.fm/LOjTi). As a medical technology company focused on developing lifesaving medical products that offer technological and clinical advantages over current standards of care, Odyssey recognizes the severity of concussions, especially in the NFL. In addition, it acknowledges the ineffectiveness of current treatment options available for patients. The Tua Tagovailoa concussion controversy has prompted the NLF and the NFLPA to revisit the league’s concussion protocol, citing a dire need to “enhance player safety.” On September 25, Tagovailoa was checked for a concussion, but the neurotrauma consultant responsible for the check made “several mistakes” in his evaluation, according to multiple reports. The Dolphins quarterback sustained a hit in the Week 3 game, but the team reported that he passed concussion protocols. On Thursday, September 29, he suffered another injury following a similar tackle, leaving him with head and neck injuries, coupled with a confirmed concussion which resulted in a trip to the hospital. The injuries following the second incident raised significant concerns and backlash, with many arguing that Tagovailoa should not have played and was in danger of serious injury. This led to the launch of an investigation, which is still ongoing. It has so far led to the termination of the neurotrauma consultant who checked Tagovailoa on September 25. On September 28, Odyssey announced the completion of all cohorts for its Phase I Single Ascending Dosing (“SAD”) and Multiple Ascending Dosing (“MAD”) clinical trial for its PRV-002 novel compound for concussion treatment. The drug proved safe and well tolerated throughout the trial, paving the way for the next phase of its clinical trial (https://ibn.fm/1puyq). PRV-002 has been shown to significantly improve both neuroscore and memory score following injury in rats subjected to concussion models. While it is yet to receive approval from the United States Food and Drug Administration (“FDA”), this compound has shown significant potential in pre-clinical studies treating concussions, going above and beyond what current alternatives in the market offer. A 2020 report published by Vox noted that American football has approximately 0.41 concussions per NFL game. The study also pointed out that 9.3% of concussions involve loss of consciousness, and 2.4% result in hospitalizations (https://ibn.fm/DAFZE). With such cases, there is a need to revise the NFL’s concussion protocol to guarantee the safety of players. There is also an urgency to push for a treatment option that effectively treats the condition. Odyssey is at the forefront of pushing a novel treatment as it advances its clinical trials with the ultimate objective of receiving FDA approval. For more information, visit the company’s website at www.OdysseyHealthInc.com. NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY

• Lexaria is a global innovator in drug delivery platforms developing DehydraTECH-CBD as a potential treatment for hypertension
• A 2022 study documented a decline in the percentage of patients receiving appropriate treatment intensification over the last ten years
• This decline has been attributed to, among other possible reasons, the side effects of antihypertensive drugs
• At the same time, only 24% of adults with hypertension have the condition under control, a statistic attributable to the medications’ troublesome side effects
• Lexaria’s investigations of its DehydraTECH-CBD have so far presented favorable safety and tolerability data, meaning its drug candidate could offer reprieve to millions looking for antihypertensive drugs with little or no side effects

A recent study published in the American Heart Association (“AHA”) journal Hypertension concluded that “appropriate treatment intensification for older adults with hypertension in the United States was suboptimal over the past decade” (https://ibn.fm/yplwP). The study results showed the percentage of patients receiving appropriate treatment intensification – described as the addition of an antihypertensive drug to the patient’s care for high blood pressure – had declined over the ten years across all the three blood pressure targets used. The study sampled adults aged 60 and older who visited their primary care provider and previously had been diagnosed with hypertension, with the researchers focusing on patients that had undergone appropriate antihypertensive intensification. Although the study did not discuss the reasons behind the decline, a recent article analyzing the findings (https://ibn.fm/tjFIr) highlighted several theories that the study’s senior author Dr. Kenneth Mukamal offered. Per Dr. Mukamal, the decline might have resulted from “doctors’ concerns that blood pressure-lowering drugs might cause older adults to fall, patients’ reluctance to add more medications that might have more side effects, [and the difficulty faced by] primary care providers to treat high blood pressure aggressively in a typical 15-minute visit.” Dr. Mukamal’s theories document an existing concern. According to the U.S. Center for Disease Control (“CDC”), only about 24% of adults with hypertension have the condition under control (https://ibn.fm/g3qjt). A commonly cited reason for this low statistic is that patients stop taking their medication largely because of troublesome side effects. Even so, a solution, which is being developed for patients with hypertension by drug delivery platforms innovator Lexaria Bioscience (NASDAQ: LEXX), may be on the horizon (https://ibn.fm/rUOYQ). Packaged in the form of enhanced cannabidiol (“CBD”), whose bioavailability properties have been improved by the company’s patented DehydraTECH(TM) drug delivery technology, the solution, known simply as DehydraTECH-CBD, may potentially address the low antihypertensive intensification as well as the relatively high prescription abandonment rates for hypertension drugs. DehydraTECH-CBD has so far undergone animal and human studies as part of preliminary investigations designed to provide crucial data that would back Lexaria’s pursuit of registration for Phase Ib clinical trials.  The preliminary research showed that DehydraTECH delivered 317% more CBD to the blood 30 minutes after ingestion, a remarkable improvement considering the oral bioavailability of CBD is estimated at 6% (https://ibn.fm/HYDPx). Further human studies showed that DehydraTECH-CBD resulted in a rapid and prolonged drop in blood pressure, reduced arterial stiffness, and attenuated pulmonary artery systolic pressure. Generally, the studies yielded compelling CBD safety and tolerability data that were further reinforced by the company’s fourth human study, HYPER-H21-4, whose dosing Lexaria completed this summer. (Studies are available at https://ibn.fm/3DuBG, https://ibn.fm/mF15O, and https://ibn.fm/TUMYz. “We are extremely pleased that dosing has been completed on time in this multiweek clinical study without any adverse events having occurred,” said Lexaria CEO Chris Bunka of the fourth human study. “Demonstrating a noteworthy safety and tolerability profile relative to conventional antihypertensive medications is one of Lexaria’s major goals with this program, and avoiding serious adverse events at clinically efficacious doses will be a primary requirement to achieve eventual regulatory marketing authorizations.” Although CBD is usually well tolerated, it could cause liver toxicity in the high therapeutic doses required to treat conditions such as epilepsy or hypertension. Currently, there is only one FDA-approved CBD therapeutic, branded Epidiolex, used to treat seizures at a maximum approved dose of up to 10 mg per kilogram of body weight, given twice a day. But Lexaria believes DehydraTECH’s ability to increase CBD’s bioavailability could reduce the dose prescribed to patients (https://ibn.fm/WcfHe). With an eye on potentially delivering the second-ever FDA-approved CBD drug, Lexaria is working with the FDA to commence registered clinical trials and is on course to file an Investigational New Drug (“IND”) application in late 2022 or early 2023. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

The GSMI Future Workforce Conference is being held on October 11-13, 2022, as a virtual event. It is a great networking opportunity designed for decision-makers, HR executives, strategy and data analytics experts, and talent acquisition professionals from diverse industries to connect and collaborate on a common platform. At the Future Workforce Conference, traders can network and connect with top executives and company heads looking for robust strategies and ideas for investing in digital, remote, and hybrid work teams in their organizations. The Future Workforce team curates tailored sponsorship experiences by integrating new processes, technologies, and strategies for evolving workplace concepts. Top reasons to attend:

• Meet the stalwarts of the industry, all under a single roof
• Design digital workplace strategies
• Learn the latest technologies, ideas and strategies to acquire and grow your talent pool
• Foster a sense of workplace culture where employee well-being holds priority
• Collaborate amongst teams for better productivity and the finest outcome
• Use data information to understand the needs and requirements of your workforce and take steps to offer them the requisite support

The Future Workforce Conference will showcase an impressive panel of speakers sharing ideas and discussing what changes are required for offering a better experience to the HR, workforce and employee teams. Our research team put together some interesting numbers for executives and company heads to study and analyze:

• When offered greater flexibility at the workplace, 54% of employees were ready to stitch their jobs
• Teleworkers showed 35-40% more productivity that their office colleagues
• Companies save about $11000 per year, with part-time per telecommunicators

The presiding faculty includes HR executives & analysts, business heads, and performance strategists from all over the globe sharing their unmatched experience and expertise. These industry dignitaries will engage with the audience, directly sharing their years of experience in their respective work areas. Professionals interested in attending the event should download and fill in the registration form available on the link below, and can share with their colleagues and company heads what sessions they will attend and other details. Attendees can leverage this wonderful event floor to learn fresh ideas, tips, and technologies of the future that are ready to change the shape of the evolving workforce in the emerging digital landscape. To learn more, please visit https://ibn.fm/8Vtj1.

• FuelPositive is a technology company developing an onsite, containerized, green ammonia production system that decarbonizes and decentralizes ammonia production
• With the world currently experiencing a fertilizer crisis, experts opine that the answer to the issue lies with the adoption of better agriculture practices rather than increased fertilizer production
• On its part, FuelPositive is working on a multi-pronged approach that eliminates not only the greenhouse emissions associated with the production of traditional (“grey”) but also the emissions linked to manure application
• The company is advocating for deep injection of green ammonia into the ground to prevent pollution of groundwater and waterbodies as is the case when manure is used

A recent article in Politico highlights a dire situation in the agricultural sector – a worldwide fertilizer crisis that has seen farmers in both developed and developing countries grappling with high fertilizer prices. The burden, however, is disproportionately higher for those in developing nations, who have less financial capacity and organization to purchase fertilizers than their European counterparts (https://ibn.fm/La85b). Although the prices were high before Russia invaded Ukraine, the situation has only worsened following the invasion, resulting in a 50% increase in the pre-invasion figures. Coupled with additional factors such as spikes in shipping costs and energy prices, EU sanctions against Russia – which is the top producer and exporter of nitrogen fertilizer, the second-largest producer of potassium, and the third-largest supplier of phosphorus fertilizer – as well as restrictions instituted by Moscow blocking fertilizer exports, this has only worsened the situation. According to the article, one of the net effects has been an upset of “the delicate balance between ensuring that farmers get paid well enough for their produce while food is affordable enough for consumers.” However, if the prices continue on an uptrend due to such additional factors as high energy prices in the EU, food prices are bound to increase as farmers seek to cover their costs. The high energy costs in Europe have also threatened fertilizer production, with producers such as Yara delivering 22% less fertilizer to farmers in the second quarter of calendar 2022. But as the article points out, the answer to the fertilizer crisis does not lie in increasing fertilizer production, especially given that overuse can cause environmental degradation by, among other things, upsetting fragile ecosystems. The solution, experts reckon, is to limit “the overuse of fertilizer by adopting more environmentally-friendly agricultural practices,” a cause that clean energy solutions provider and technology company FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is also championing. On its part, FuelPositive has taken a multi-pronged approach that aims to produce green ammonia and push for the adoption of sustainable agricultural practices that eliminate pollution. Today, about 80% of the ammonia produced globally through energy- and emissions-intensive processes, one of which is the Haber Bosch process, is used in agriculture as a key source of nitrogen for fertilizer. (Nitrogen is agriculture’s most vital nutrient, given that plants absorb more nitrogen than any other element.) With the United Nations having predicted that the global demand for nitrogen fertilizers will have grown by 6% between 2017 and 2022, a growth trend that is set to continue or even accelerate (https://ibn.fm/yWQwj), meeting the demand will require the production of more ammonia. However, traditional methods of generating the compound emit three metric tonnes of greenhouse gases for every tonne of grey ammonia produced, a cause of great concern amid ongoing extreme weather events brought by climate change. FuelPositive has, therefore, developed an on-farm, containerized, green ammonia production system that decarbonizes ammonia production by relying on renewable electricity to synthesize hydrogen and nitrogen from water and air, respectively, before combining the molecules in a converter to create green ammonia. The system also provides an additional advantage: it decentralizes green ammonia production. This frees farmers from supply chain dependencies that can increase their vulnerability to disruptive events such as wars or price hikes due to increasing shipping prices. Similarly, farmers do not have to rely on manufacturers whose ability to produce and export nitrogen fertilizer is at the whim of government directives, energy prices and catastrophic weather. The company is on track to be fully validated and ready to deliver the first demonstration system of its green ammonia technology to a farm in Manitoba in the fall of 2022 as part of a demonstration pilot project. Moreover, it is accepting pre-sale orders (https://ibn.fm/N2nvS). FuelPositive believes its green ammonia system will enable farmers to sufficiently produce nitrogen fertilizer and, ultimately, power their generators, grain drying systems, ICE vehicles, and other farm equipment. In addition, FuelPositive is advocating for the deep injection of green ammonia to solve the emissions problem associated with manure use. A byproduct of farm animals, manure contains ammonia and is sprayed on the ground to act as a natural source of nitrogen. But its use as a fertilizer is considered pollutive when not handled appropriately. For example, manure releases gaseous ammonia into the atmosphere when sprayed on the ground. Additionally, the manure can be moved by rain and runoff into waterways or leech into groundwater, increasing nitrate levels and subsequently impacting the water quality (https://ibn.fm/gybh9). “In comparison to using manure as fertilizer, deep injection of green ammonia eliminates the emissions associated with manure,” the company’s website reads (https://ibn.fm/FPN3D). For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• The growing environmental regulations are prompting companies to explore ways to meet ESG (Environmental, Social, and Governance) goals, but which can come at a hefty up-front cost, a significant disadvantage to small and medium enterprises
• Energy optimization solution provider Correlate, through its smart team of experts and evolving technologies, makes solutions extremely affordable to more companies, businesses, and real estate owners
• The company has positioned itself as a one-stop shop for those looking to explore renewable energy sources, reduce their carbon emissions, meet government regulations, and achieve their ESG goals, covering all aspects, including planning, financing, and execution

Environmental, Social, and Governance (“ESG”) goals are becoming more integral in corporate America, with many players looking to preserve precious resources and slash their carbon emissions. In addition, the growing number of environmental regulations in the country is prompting companies to re-align their operations and explore new ways to meet the current standards. This shift has triggered resource-intensive efforts, including electrifying older buildings and, according to Marta Schantz, the co-executive director of Urban Land Institute, looking for talent with the right analytics experience and skills (https://ibn.fm/sEqDe). These efforts come at a hefty up-front cost, a significant disadvantage to small and medium enterprises. However, Correlate Infrastructure Partners (OTCQB: CIPI), a driver of highly cost-effective solutions for energy use optimization, is looking to make such privileges more accessible to more companies, businesses, and real estate owners through its financing program that makes upgrades extremely affordable. “The quest for ESG talent has never been bigger,” noted Mr. Schantz. “Everyone wants to be doing more on climate, there’s not enough staff to do it, and no one person can be an expert on all the different aspects of ESG that needs to be covered,” he added. Since it was founded in 2015, Correlate has always recognized a glaring opportunity in the industry, especially in the wake of mounting environmental regulations and the call for companies to reduce their carbon emissions. Starting as a portfolio-scale development and finance platform offering commercial and industrial facilities access to clean electrification solutions, Correlate managed to venture into the solar energy and electric vehicle (“EV”) infrastructure sectors. Its acquisition of Solar Site Design in 2021 allowed Correlate to improve on its customer acquisition and project development for the commercial solar industry, ultimately growing its market share and having the ability to cater to even bigger customers. Today, the company has positioned itself as a one-stop shop for companies and real estate owners looking to explore renewable energy projects, reduce their carbon emissions, meet government regulations and achieve their ESG goals. “Correlate Infrastructure Partners loves supporting ESG-focused businesses that are making a true difference in their industries and communities,” noted Todd Michaels, Correlate’s Chief Executive Officer (“CEO”), during the announcement of the final engineering, permitting, and interconnection work at Continental Envelope (https://ibn.fm/6oqjZ). Correlate, through the systems and infrastructure it has built over the years, can offer unique solutions specifically designed to solve current problems within the United States market. Covering everything from planning to financing and execution has given it a significant competitive edge while doing away with small companies’ need to actively pursue certain ESG investments, including talent with the right analytics experience and skills. Going forward, Correlate plans to make it increasingly simple for people to find the company and take advantage of its offerings. It is well conversant with the current legal space from an environmental standpoint and is well equipped to help companies achieve their ESG goals. It looks to achieve this through its ever-growing team of experts, as well as its evolving technologies. For company information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Hurricane Ian is the latest reminder that 83% of all major power outages are weather related
• GeoSolar Technologies SmartGreen(TM) homes include rooftop solar panels, battery systems, geothermal loops and electric air pump, premium insulation and more
• Installing a SmartGreen(TM) system reduces emissions by 8 tons annually and can eliminate energy-related utility bills

Devastating weather events like Hurricane Ian regularly leave millions of people throughout the path of the storm without power. In fact, it weather is nearly always responsible for major power outages, the culprit in 83% between 2000 and 2021, according to Climate Central. This begs the question of what can be done to help develop resilience? An answer: renewable energy and all-home solutions like that of GeoSolar Technologies (“GST”). Research this year by Berkeley Lab evaluated models of power outages throughout the U.S. and the potential for rooftop solar panels combined with battery systems to handle critical power loads. While there are considerable variables across the country – some regions use power-gobbling electric resistance heaters rather than efficient heat pumps, for example – the researchers found that even modestly sized systems could power a home for days at a time. Addition support in the case for solar is being lent by the ZeMod Delaware program, where Energize Delaware is working with Beracah Homes and the Milford Housing Development Corp. to offer people modular, solar-powered homes at prices significantly lower than the state’s current median home price. Energize Delaware is a non-profit providing grants and low-interest loans to help the state’s residents install solar and complete upgrades to be more energy efficient. For its part, GeoSolar offers an end-to-end solution to build new homes or retrofit existing homes with leading energy-efficient technologies. The company’s SmartGreen(TM) Home harnesses the power of the sun and earth to electrify a home while significantly reducing the owner’s pollutive footprint. The Denver-based company estimates installation of it whole-home solution cuts CO2 emissions by 800 pounds each year with the added monetary perk of reducing or eliminating utility bills. A GeoSolar home includes installation of geothermal ground loops and heat pump, electric water heater, premium insulation to ensure the building shell keeps the interior temp in and outside temp out, roof-mounted solar panels, upgraded, high-efficiency windows, CERV 2 air purification system, LED lighting, and a Storz battery backup system. Other options include a solar-powered hot tub, EV charging station, electric appliance upgrades, Xeriscape Landscape and water harvesting, and advance whole home water filtration system. The result is a home that has an efficiency rating that ranks amongst the highest in the industry based upon the Home Energy Rating System (“HERS(R)”) Index. The company even helps with arranging financing and suggests on its website that the savings from the elimination of utility bills can cover the cost of the SmartGreen(TM) products. Considering that a typical carbon-powered home in the U.S. uses 12,146 kilowatt hours of electricity and produces 8 metric tons of CO2 emissions every year, investing in systems like SmartGreen(TM) can have a meaningful effect on climate change. GeoSolar says that if it can apply its integrated system to 120 million homes, buildings, and businesses in the U.S., carbon emissions would be slashed by a whopping 60 trillion tons. This goes without mentioning reducing the strain on an aging and overloaded electric grid and being able to weather storms when power typically might be lost. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST